Atlas Trials

Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer

Clinical trial NCT00924807 · TERMINATED

Trial details

NCT number
NCT00924807
Sponsor
Beth Israel Medical Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2008-09-01
Primary completion
2013-12-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.